Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tissue factor in acute coronary syndromes].

B A Steppich1, I Ott

  • 1Deutsches Herzzentrum der Technischen Universität München, Lazarettstr. 36, 80636 München.

Hamostaseologie
|May 6, 2006
PubMed
Summary

Tissue factor (TF) initiates blood clotting in acute coronary syndromes. This review explores TF's role in plaque rupture, thrombosis, and inflammation, discussing potential therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cobalt-based metallo-mesoionic carbene gold complexes with antiproliferative effects.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Stem Cell Therapy after Acute Myocardial Infarction-The Emperor's New Clothes?: Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients with Acute Myocardial Infarction: A Randomized Controlled Trial. JAMA 295: 1003-1010, 2006.

Journal of the American Society of Nephrology : JASN·2023
Same author

Note on Croton-Chloral-Hydrate.

Atlanta medical and surgical journal·2022
Same author

The antioxidant 2,6-di-tert-butylphenol moiety attenuates the pro-oxidant properties of the auranofin analogue.

Metallomics : integrated biometal science·2018
Same author

Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.

Neuropathology and applied neurobiology·2017
Same author

Percutaneous edge-to-edge repair in tricuspid and mitral valve regurgitation.

Herz·2017

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pathophysiology

Context:

  • Acute coronary syndromes (ACS) result from atherosclerotic plaque rupture and subsequent thrombosis.
  • Tissue factor (TF) is a key initiator of the extrinsic coagulation cascade, central to ACS pathogenesis.
  • Both local plaque-associated and circulating TF influence thrombotic extent.

Purpose:

  • To review current understanding of TF's role in ACS.
  • To discuss TF's involvement in inflammatory signaling and vascular remodeling.
  • To explore potential therapeutic strategies targeting TF in ACS.

Summary:

  • TF initiates coagulation, driving thrombosis in ACS.
  • TF contributes to inflammation and vascular remodeling.
  • Understanding TF's multifaceted role is crucial for developing new ACS treatments.

Impact:

  • Highlights TF as a critical target for ACS intervention.
  • Provides insights into the pathophysiology of ACS.
  • Informs the development of novel antithrombotic and anti-inflammatory therapies.

Related Experiment Videos